Lans Taylor, PhD Profile Photo

Lans Taylor, PhD

Lans was Co-Founder and CEO of Cellomics Inc., which developed and commercialized High Content Screening (HCS) that permitted single cell quantitation of multiplexed fluorescence biomarkers in arrays of cells and tissues. In addition to Cellomics, Dr. Taylor co-founded several other biotech companies, such as Biological Detection Systems, Inc. and Cernostics, Inc., and is an expert in multiplexed fluorescence and biomarker imaging.

April 30, 2022

Precision Pathology Using Explainable AI

2022 has turned out to be an extremely pivotal year for computational pathology with major announcements coming out of USCAP and …

Episode page